期刊文献+

儿科重症监护病房血管内导管相关性血流感染病原菌分布特点及耐药性分析 被引量:19

Distribution of pathogen species and antibiotic resistance of pathogens from intravenous catheter-related bloodstream infections in pediatric intensive care unit
原文传递
导出
摘要 目的 了解儿科重症监护病房(PICU)血管内导管相关性血流感染(CRBSIs)的临床特点、病原菌分布及其耐药性,为合理使用抗生素提供依据.方法 回顾性分析2009年9月至2014年9月在广东省人民医院PICU住院的CRBSIs患儿的临床特点、病原菌构成和药物敏感试验结果.结果 5年共使用中心静脉导管10 834 d,发生CRBSIs 23例,发病率为2.1/1 000导管日.置管时间<7d9例(占39.1%),8-14 d 10例(占43.5%),14-21 d 4例(占17.4%).革兰阳性菌13例(占56.6%),革兰阴性菌5例(占21.7%),真菌5例(占21.7%).引起CRBSIs的主要病原菌依次为凝固酶阴性葡萄球菌(7株,占30.4%)、金黄色葡萄球菌(3株,占13.0%)、白色念珠菌(3株,占13.0%)、近平滑念珠菌(2株,占8.7%)、阴沟肠杆菌(2株,占8.7%).表皮葡萄球菌等凝固酶阴性葡萄球菌未发现万古霉素、利奈唑胺、替考拉宁耐药菌株;革兰阴性杆菌对亚胺培南、哌拉西林/三唑巴坦、头孢哌酮/舒巴坦、阿米卡星敏感率均为100%;白色念珠菌、近平滑念珠菌对两性霉素B、5-氟胞嘧啶、氟康唑、伏立康唑敏感率均为100.0%.21例(91.3%)曾用抗生素,2例(8.7%)未用.真菌感染者平均使用抗生素4.4种,细菌为1.4种.曾用1种的10例(43.5%),2种的4例(17.4%),3种的4例(17.4%),3种以上的5例(21.7%).痊愈22例(95.7%),死亡1例(4.3%).结论 PICU内CRBSIs病原菌以凝固酶阴性葡萄球菌为主,延长导管留置时间且频繁使用多种抗生素者,需警惕真菌感染.规范使用抗菌药物,缩短置管时间是预防CRBSIs的有效措施,监测CRBSIs病原菌分布和药敏变迁有助于早期经验性用药. Objective To investigate the clinical characteristics,distribution and drug sensitivity of pathogens causing intravenous catheter-related bloodstream infections (CRBSIs) in pediatric intensive care unit (PICU) so as to use antibiotics reasonably.Methods All patients with CRBSIs in PICU of Guangdong General Hospital from September 2009 to September 2014 were investigated and the drug resistance profiles of pathogens causing CRBSIs were also analyzed retrospectively.Results Between 2009 and 2014,there were totally 10 834 catheter days and 23 episodes of CRBSIs with an incidence of 2.1 infections per 1 000 catheter days.Catheter indwell time 〈 7 days in 9 cases (39.1%),8 to 14 days in 10 cases (43.5%),14 to 21 days in 4 cases (17.4%).There were 13 strains (56.6%) of gram-positive bacteria,5 strains (21.7%) of gram-negative bacteria and 5 strains (21.7%) of fungi.The main pathogens causing CRBSIs were coagulase negative Staphylococci (7 strains,30.4%),Staphylococcus aureus (3 strains,13.0%),Candida albicans(3 strains,13.0%),Candida parapsilosis(2 strains,8.7%),and Enterobacter cloacae (2 strains,8.7 %).The susceptibility to Vancomycin,Linezolid and Teicoplanin of coagulase negative Staphylococ cus such as S.epidermidis and to Imipenem,Piperacillin/Tazobactam,Cefoperazone/ Sulbactam and Amikacin of gram-positive bacteria arrived at 100.0%,respectively.The candida were 100% susceptible to Amphotericin B,5-Flucytosine,Fluconazole and Voriconazole.Twenty-one cases (91.3%) received antibiotic treatment versus no antibiotic in 2 cases (8.7%).The average number of antibiotic kinds administered on the patients with fungal infection was 4.4,bacteria were 1.4.Ten cases (43.5%) treatment with 1 kind of antibiotic,4 cases (17.4%) with 2,4 cases (17.4%) with 3,5 cases (21.7%) with more than 3.Twenty-two cases (95.7%) cured and 1 case died (4.3%).Conclusions The major species of pathogen causing CRBSIs was coagulase negative staphylococci in PICU.It is critical for clinicians to guard against fungal infection because of prolonged catheter indwelling time and more antibiotics administered before indwelling catheter.It is effective way to prevent the CRBSIs by reasonably using antibiotics and shortening the time of catheter indwelling.Monitoring CRBSIs pathogenic bacteria distribution and drug susceptibility helps reasonable administration of antibiotics in the earlier time.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2015年第12期929-933,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 卫生部2012年医院感染控制标准制(修)订计划项目(20121303) 广东省医学科研基金(A2013027)
关键词 儿科重症监护病房 导管相关性血流感染 病原菌 耐药性 Pediatric intensive care unit Catheter-related bloodstream infections Pathogen Drug resistance
  • 相关文献

参考文献18

  • 1OdetolaFO,MolerFW,DechertRE,et al.Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit:risk and rates associated with various intravascular technologies[J].Pediatr Crit Care Med,2003,4(4):432-436.
  • 2GahlotR,NigamC,KumarV,et al.Catheter-related bloodstream infections[J].Int J Crit Illn Inj Sci,2014,4(2):162-167.
  • 3AdlerA,YanivI,SteinbergR,et al.Infectious complications of implan-table ports and Hickman catheters in paediatric haematology-oncology patients[J].J Hosp Infect,2006,62(3):358-365.
  • 4FratinoG,MolinariAC,ParodiS,et al.Central venous catheter-related complications in children with oncological/hematological diseases:an observational study of 418 devices[J].Ann Oncol,2005,16(4):648-654.
  • 5OnderAM,KatoT,SimonN,et al.Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters[J].Pediatr Transplant,2007,11(1):87-93.
  • 6PinonM,BezzioS,TovoPA,et al.A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital[J].Eur J Pediatr,2009,168(12):1505-1512.
  • 7RobinsonJL,CaseyLM,HuynhHQ,et al.Prospective cohort study of the outcome of and risk factors for intravascular catheter-related bloodstream infections in children with intestinal failure[J].JPEN J Parenter Enteral Nutr,2013,38(5):625-630.
  • 8PiperHG,WalesPW.Prevention of catheter-related blood stream infections in children with intestinal failure[J].Curr Opin Gastroenterol,2013,29(1):1-6.
  • 9NewmanCD.Catheter-related bloodstream infections in the pediatric intensive care unit[J].Semin Pediatr Infect Dis,2006,17(1):20-24.
  • 10MermelLA,AllonM,BouzaE,et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 update by the infectious diseases society of America[J].Clin Infect Dis,2009,49(1):1-45.

二级参考文献31

共引文献48

同被引文献156

  • 1重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:426
  • 2都丽萍,梅丹.药源性血小板减少症的发病机制和临床表现及防治[J].药物不良反应杂志,2007,9(6):414-419. 被引量:87
  • 3Bramesfeld A,Wrede S,Richter K,et al.Development of quality indicators and data assessment strategies for the prevention of central venous catheter-related bloodstream infections(CRBSI)[J].BMC Infect Dis,2015,15:435.
  • 4Saravu K,Prasad M,Eshwara VK,et al.Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital-aprospective cohort study[J].Pathog Glob Health,2015,109(5):228-235.
  • 5Ong DS,Bonten MJ,Safdari K,et al.Epidemiology,management,and risk-adjusted mortality of ICU acquired enterococcal bacteremia[J].Clin Infect Dis,2015,61(9):1413-1420.
  • 6Yamada M,Nakai K,Yamamichi K,et al.A successfully treated case of central venous catheter-related suppurative thrombophlebitis of the rightjugular vein to the superior vena cava associated with esophageal cancer[J].Gan To Kagaku Ryoho,2015,42(7):855-857.
  • 7Youn SH,Lee JC,Kim Y,et al.Central venous catheter-related infection in severe trauma patients[J].World J Surg,2015,39(10):2400-2406.
  • 8Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravas cular catheter-related infection:2009 update by the infec tious diseases society of America[J]. Clin Infect Dis, 2009,49(1):1-45.
  • 9Ammendolia MG, Di Rosa R, Montanaro L, et al. Slime production and expression of the slime-associaled antigen by staphylococcal clinical isolates [J]. J Clin Microbiol, 1999,37(10) :3235-3238.
  • 10Turhan EE,Gtirsoy T, Oval F. Factors which affect mor tality in neonatal sepsis[J]. Turk Pediatr, 2015,50 (3) : 170-175.

引证文献19

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部